Abstract
Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation via a specific interaction with factor VIII. In the presence of endothelial cells, the intrinsic activation of factor X was inhibited by protein S with an IC50 value of 0.28 +/- 0.04 mu mol/L corresponding to the plasma concentration of protein S. This inhibitory effect was even more pronounced when the intrinsic factor X activation was studied in the presence of activated platelets (IC50 = 0.15 +/- 0.02 mu mol/L). When a nonlimiting concentration of phospholipid vesicles was used, the plasma concentration of protein S (300 nmol/L) inhibited the intrinsic factor X activation by 40%. Thrombin-cleaved protein S inhibited the endothelial cell-mediated factor X activation with an IC50 similar to that of native protein S (0.26 +/- 0.02 mu mol/L). Protein S in complex with C4b-binding protein inhibited the endothelial cell-mediated factor X activation more potently than protein S alone (IC50 = 0.19 +/- 0.03 mu mol/L). Using thrombin activated factor VIII, IC50 values of 0.53 +/- 0.09 mu mol/L and 0.46 +/- 0.10 mu mol/L were found for native protein S and thrombin-cleaved protein S, respectively. The possible interactions of protein S with factor IXa, phospholipids, and factor VIII were investigated. The enzymatic activity of factor IXa was not affected by protein S, and interaction of protein S with the phospholipid surface could not fully explain the inhibitory effect of protein S on the factor X activation. Using a solid-phase binding assay, we showed a specific, saturable, and reversible binding of protein S to factor VIII with a high affinity. The concentration of protein S where half-maximal binding was reached (B-1/2max) was 0.41 +/- 0.06 mu mol/L. A similar affinity was found for the interaction of thrombin-cleaved protein S with factor VIII (B-1/2max = 0.40 +/- 0.04 mu mol/L). The affinity of the complex of protein S with C4B-binding protein appeared to be five times higher (B-1/2max = 0.07 +/- 0.03 mu mol/ L). Because the affinities of the interaction of the different forms of protein S with factor VIII correspond to the ICS, values observed for the intrinsic factor X activating complex, the interaction of protein S with factor VIII may explain the inhibitory effect of protein S on the intrinsic factor X activating complex. These data suggest that protein S exerts an activated protein C independent anticoagulant function, not only by inhibiting the prothrombinase reaction, but also by inhibiting the intrinsic activation of factor X. (C) 1995 by The American Society of Hematology.
| Original language | English |
|---|---|
| Pages (from-to) | 1062-1071 |
| Number of pages | 10 |
| Journal | Blood |
| Volume | 86 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Aug 1995 |
| Externally published | Yes |
Keywords
- GAMMA-CARBOXYGLUTAMIC ACID
- HUMAN ENDOTHELIAL-CELLS
- FACTOR-VA INACTIVATION
- C4B-BINDING PROTEIN
- VONWILLEBRAND-FACTOR
- THROMBOTIC DISEASE
- VENOUS THROMBOEMBOLISM
- COFACTOR ACTIVITY
- C DEFICIENCY
- BOVINE
Fingerprint
Dive into the research topics of 'INHIBITION OF THE INTRINSIC-FACTOR-X ACTIVATING COMPLEX BY PROTEIN-S - EVIDENCE FOR A SPECIFIC BINDING OF PROTEIN-S TO FACTOR-VIII'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver